Seaport Therapeutics, Inc.
SPTX
$24.22
$0.512.15%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -146.38% | -14.87% | |||
| Total Depreciation and Amortization | -1.68% | 12.38% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 1,456.01% | -27.04% | |||
| Change in Net Operating Assets | -115.63% | 85.65% | |||
| Cash from Operations | -29.59% | 24.15% | |||
| Capital Expenditure | -- | -398.15% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -830.71% | 99.48% | |||
| Cash from Investing | -830.71% | 99.36% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 200.00% | -- | |||
| Cash from Financing | 30,869.86% | -- | |||
| Foreign Exchange rate Adjustments | 203.57% | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 64.76% | 93.18% | |||